Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by bfwon Jul 18, 2018 11:50am

172 Views

Post# 28333014

RE:RE:RE:green today

You posted this under the wrong handle.

It was supposed to be OKTP160 like your last post about Trimeris :)

bfw

Pawscari wrote: Agree.

The trend is obvious, people should wait before they decided to hop on.

The sales result ended up very bad compare to Fuzeon.

1. Fuzeon was more expensive than expected too

2. Fuzeon was brand new thing that takes doctors to adapt to it too

3. Fuzeon has even more serious insurance issue because it was before Obamacare

But Fuzeon got 600 patients per month in the first season. Trogarzo only got 100 patients(excluded EMA 100 patients)

Another interesting fact, Trimeris's SP was at its peak right after the Fuzeon was on sale. When the Fuzeon reached its sales peak which if I remember correctly was 2007, the SP already dropped to less than half.

Still holding Taimed and TH stocks, just look for discussion that address to the sales team problem of Theratechnologies..

Thanks guys